Details of the Drug
General Information of Drug (ID: DMU04ZQ)
| Drug Name |
1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
naphyrone; 1-(Naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one; 850352-11-3; 850352-53-3; Naphyrone (O-2482); CHEMBL204759; naphthylpyrovalerone; beta-Naphyrone; O-2482; 1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one; SCHEMBL4939526; DEA No. 1258; CTK8C0838; ACT06821; BDBM50182546; ANW-65341; AKOS015898953; KB-215797; AX8234386; AB1004335; TC-154086; I14-12001; 1-Pentanone, 1-(2-naphthalenyl)-2-(1-pyrrolidinyl)-; 850352-53-3,850352-11-3(HCl); 1-(1-(naphthalen-2-yl)-1-oxopentan-2-yl)pyrrolidinium chloride
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 281.4 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 4.7 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 5 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


